15 Vaccines and 5 booster doses approved so far in India: CDSCO

With the approval of 15 vaccines for primary vaccination and five for booster doses, the country has navigated through complexities, ensuring a robust defense against the pandemic.

170
CDSCO Central Drug Standard Control Organisation
CDSCO

Last Updated on December 31, 2023 by The Health Master

Vaccines

India has been at the forefront of the battle against Covid-19, and its vaccines stands as a testament to its resilience.

With the approval of 15 vaccines for primary vaccination and five for booster doses, the country has navigated through complexities, ensuring a robust defense against the pandemic.

Recent Booster Dose Approvals in 2023

In a latest update from the Central Drugs Standard Control Organisation (CDSCO), booster dose approvals were granted for Covovax, ZyCoV-D, and Gemcovac – OM in 2023.

These approvals play a pivotal role in enhancing immunity and tackling emerging variants of the virus.

2022 Approvals for Vaccines

The year 2022 witnessed approvals for primary vaccination series, including vaccines: Sputnik-V, Panacea Biotec, Hetero Biopharma, and others.

However, the approval process faced criticism, raising concerns about patient safety and the thoroughness of the evaluation.

Vaccination Coverage and Statistics

Medicine Injection Vaccine
Picture: Pixabay

As of November 30, 2023, India’s vaccination coverage has surpassed 220.67 Crore, with 318 active cases, 4.44 Crore recoveries, and 4.33 lakh reported deaths.

The recovery rate stands at an impressive 98.81 percent. Additionally, India has exported 3012.465 lakh vials to 101 countries, showcasing its global contribution.

Global Impact: Export of Vaccines

India’s role in global vaccination efforts is significant, with millions of vaccines exported to countries in need.

This highlights India’s commitment to global health and solidarity in the fight against the pandemic.

Criticisms and Safety Concerns

Despite the success of the vaccination program, the approval process faced criticism for allegedly skipping important safety steps.

Addressing these concerns is crucial for maintaining public trust and ensuring the effectiveness of the vaccines.

Economic Survey 2022-23 Insights

The Economic Survey 2022-23 sheds light on the comprehensive efforts behind India’s National Covid-19 Vaccination Programme.

Starting in January 2021, the program aimed to cover the adult population swiftly, later expanding to include younger age groups and precautionary doses.


Must read: FAQs on C-19 vaccination: must read


Challenges and Achievements

The vaccination program encountered numerous challenges, from research and development to logistical issues.

Overcoming these hurdles, the program achieved its goals efficiently, showcasing the resilience and adaptability of India’s healthcare system.

Role of Co-WIN in Vaccination

The introduction of Co-WIN, a cloud-based IT solution, played a pivotal role in the vaccination program.

This platform provided end-to-end solutions, ensuring accountability and transparency in vaccines distribution, reducing wastage, and facilitating real-time stock tracking.

Accountability and Transparency

Co-WIN addressed the critical aspects of accountability and transparency in vaccines supply chains.

Its real-time stock tracking at national, state, and district levels, both in government and private sectors, prevented vaccines wastage and enhanced efficiency.

Digital Verifiable Certificates

Co-WIN not only facilitated vaccination but also issued digitally verifiable certificates in 12 regional languages.

Aligned with WHO Guidelines, these certificates proved invaluable for international travelers, showcasing India’s commitment to global health standards.

FAQs

  1. What is the significance of booster doses in managing the pandemic?
    • Booster doses play a crucial role in enhancing immunity and addressing emerging variants of the virus, ensuring prolonged protection.
  2. How many vaccines has India exported globally?
    • India has exported 3012.465 lakh vials to almost 101 countries, contributing significantly to global vaccination efforts.
  3. Were safety concerns adequately addressed during the approval process?
    • The approval process faced criticism, emphasizing the need for continuous improvement in ensuring patient safety and thorough evaluations.
  4. How does Co-WIN contribute to the vaccination program?
    • Co-WIN, a comprehensive IT solution, ensures accountability, transparency, and efficiency in vaccines distribution, reducing wastage.
  5. Can Co-WIN certificates be used for international travel?
    • Yes, Co-WIN certificates are designed following WHO Guidelines and are digitally verifiable, making them suitable for international travelers.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news